Business Standard

Vista Pharmaceuticals standalone net profit declines 88.76% in the March 2017 quarter

Image

Capital Market

Sales rise 5.88% to Rs 6.12 crore

Net profit of Vista Pharmaceuticals declined 88.76% to Rs 0.10 crore in the quarter ended March 2017 as against Rs 0.89 crore during the previous quarter ended March 2016. Sales rose 5.88% to Rs 6.12 crore in the quarter ended March 2017 as against Rs 5.78 crore during the previous quarter ended March 2016.

For the full year,net profit rose 49.35% to Rs 1.15 crore in the year ended March 2017 as against Rs 0.77 crore during the previous year ended March 2016. Sales rose 57.22% to Rs 24.18 crore in the year ended March 2017 as against Rs 15.38 crore during the previous year ended March 2016.

 
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales6.125.78 6 24.1815.38 57 OPM %10.1323.36 -12.6116.97 - PBDT0.341.15 -70 2.151.86 16 PBT0.100.89 -89 1.130.84 35 NP0.100.89 -89 1.150.77 49

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 31 2017 | 5:32 PM IST

Explore News